Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 6, Pages 5034-5043
Publisher
Wiley
Online
2017-12-08
DOI
10.1002/jcp.26369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2
- (2017) Yuchun Niu et al. Molecular Cancer
- Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
- (2017) Julia Joung et al. NATURE
- Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway
- (2017) Yan Pan et al. Oncotarget
- Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
- (2017) Rong Liu et al. Scientific Reports
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Genome-wide changes in lncRNA, splicing and regional gene expression patterns in autism
- (2016) Neelroop N. Parikshak et al. NATURE
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling
- (2016) Andreas Wicki et al. PHYSIOLOGICAL REVIEWS
- Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer
- (2016) Angel Diaz-Lagares et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
- (2015) Yu Yu et al. CANCER CELL
- Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α
- (2015) Yanlei Ma et al. GUT
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory
- (2015) Eli Raveh et al. Molecular Cancer
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Alpha2beta1 integrin in cancer development and chemoresistance
- (2015) Dalila Naci et al. SEMINARS IN CANCER BIOLOGY
- HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
- (2015) Andrew E. Teschendorff et al. Genome Medicine
- The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia
- (2014) A Giannoudis et al. LEUKEMIA
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
- (2014) Brian Gloss et al. Molecular Cancer
- A novel long non-coding RNA-ARA: Adriamycin Resistance Associated
- (2013) Min Jiang et al. BIOCHEMICAL PHARMACOLOGY
- Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal
- (2013) Yue Wang et al. DEVELOPMENTAL CELL
- The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs
- (2013) Amanda N. Kallen et al. MOLECULAR CELL
- Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
- (2012) J.-P. Gillet et al. CLINICAL CANCER RESEARCH
- Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
- (2012) Johnson J. Liu et al. CURRENT CANCER DRUG TARGETS
- Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
- (2012) Isabelle Soerjomataram et al. LANCET
- Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat
- (2012) Claudia Carrieri et al. NATURE
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
- (2011) M. N. Cabili et al. GENES & DEVELOPMENT
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
- (2009) Meng Li et al. BMC Medical Genomics
- High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
- (2009) W-F Cheng et al. BRITISH JOURNAL OF CANCER
- RNAplex: a fast tool for RNA–RNA interaction search
- (2008) Hakim Tafer et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now